Commerce Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.5M Buy
281,297
+201,812
+254% +$26.6M 0.16% 129
2026
Q1
$11.1M Buy
79,485
+3,463
+5% +$485K 0.05% 240
2025
Q4
$9.33M Sell
76,022
-4,141
-5% -$503K 0.05% 223
2025
Q3
$8.9M Buy
80,163
+2,240
+3% +$255K 0.05% 231
2025
Q2
$8.64M Buy
77,923
+6,046
+8% +$643K 0.05% 227
2025
Q1
$8.05M Sell
71,877
-1,318
-2% -$136K 0.05% 241
2024
Q4
$6.76M Buy
73,195
+701
+1% +$63.1K 0.04% 262
2024
Q3
$6.08M Buy
72,494
+7,055
+11% +$538K 0.04% 282
2024
Q2
$4.49M Sell
65,439
-813
-1% -$54.3K 0.03% 323
2024
Q1
$4.85M Buy
66,252
+2,034
+3% +$156K 0.03% 319
2023
Q4
$5.2M Buy
64,218
+203
+0.3% +$15.8K 0.04% 303
2023
Q3
$4.8M Sell
64,015
-290
-0.5% -$22.3K 0.04% 287
2023
Q2
$4.96M Sell
64,305
-1,621
-2% -$129K 0.04% 290
2023
Q1
$5.47M Buy
65,926
+27
+0% +$2.24K 0.04% 270
2022
Q4
$5.66M Sell
65,899
-418
-0.6% -$33.1K 0.05% 253
2022
Q3
$4.09M Sell
66,317
-169
-0.3% -$10.7K 0.04% 290
2022
Q2
$4.11M Sell
66,486
-489
-0.7% -$30.3K 0.03% 306
2022
Q1
$3.98M Sell
66,975
-20,408
-23% -$1.3M 0.03% 355
2021
Q4
$6.34M Buy
87,383
+3,188
+4% +$220K 0.04% 277
2021
Q3
$5.88M Buy
84,195
+6,753
+9% +$474K 0.04% 282
2021
Q2
$5.33M Buy
77,442
+6,376
+9% +$426K 0.04% 307
2021
Q1
$4.59M Sell
71,066
-2,547
-3% -$164K 0.03% 330
2020
Q4
$4.29M Sell
73,613
-2,407
-3% -$145K 0.03% 336
2020
Q3
$4.8M Buy
76,020
+7,092
+10% +$492K 0.04% 278
2020
Q2
$5.3M Sell
68,928
-115,588
-63% -$8.86M 0.05% 237
2020
Q1
$13.8M Buy
184,516
+4,326
+2% +$299K 0.17% 116
2019
Q4
$11.7M Buy
180,190
+8,352
+5% +$544K 0.11% 137
2019
Q3
$10.9M Buy
171,838
+80,927
+89% +$5.29M 0.11% 142
2019
Q2
$6.14M Buy
90,911
+4,975
+6% +$327K 0.07% 181
2019
Q1
$5.59M Sell
85,936
-522
-0.6% -$34.7K 0.07% 182
2018
Q4
$5.41M Buy
86,458
+3,291
+4% +$230K 0.07% 175
2018
Q3
$6.42M Buy
83,167
+28,848
+53% +$2.18M 0.08% 171
2018
Q2
$3.85M Sell
54,319
-651
-1% -$46K 0.05% 213
2018
Q1
$4.14M Buy
54,970
+761
+1% +$60.5K 0.05% 204
2017
Q4
$3.88M Buy
54,209
+393
+0.7% +$29.8K 0.05% 212
2017
Q3
$4.36M Buy
53,816
+1,722
+3% +$132K 0.06% 197
2017
Q2
$3.69M Sell
52,094
-6,346
-11% -$422K 0.05% 211
2017
Q1
$3.97M Buy
58,440
+83
+0.1% +$5.84K 0.06% 196
2016
Q4
$4.18M Sell
58,357
-2,050
-3% -$152K 0.06% 193
2016
Q3
$4.78M Sell
60,407
-10,604
-15% -$861K 0.07% 178
2016
Q2
$5.92M Sell
71,011
-14,794
-17% -$1.31M 0.09% 163
2016
Q1
$7.88M Buy
85,805
+1,134
+1% +$102K 0.13% 144
2015
Q4
$8.57M Sell
84,671
-2,003
-2% -$208K 0.14% 138
2015
Q3
$8.51M Buy
86,674
+3,422
+4% +$380K 0.15% 135
2015
Q2
$9.75M Sell
83,252
-360
-0.4% -$39.3K 0.15% 131
2015
Q1
$8.21M Buy
83,612
+4,040
+5% +$410K 0.13% 146
2014
Q4
$7.5M Buy
79,572
+9,966
+14% +$1.03M 0.12% 149
2014
Q3
$7.41M Buy
69,606
+3,674
+6% +$360K 0.12% 145
2014
Q2
$5.47M Buy
65,932
+1,547
+2% +$120K 0.09% 166
2014
Q1
$4.56M Buy
64,385
+2,824
+5% +$221K 0.08% 175
2013
Q4
$4.62M Buy
61,561
+574
+0.9% +$40K 0.08% 171
2013
Q3
$3.83M Sell
60,987
-15
-0% -$896 0.07% 182
2013
Q2
$3.13M Buy
+61,002
New +$3.18M 0.06% 198

Other funds holding GILD

Commerce Bank's GILD Position: Q2 2026 in Review

Commerce Bank increased its Gilead Sciences (GILD) stake by 254% in Q2 2026, buying an estimated $26.6M and bringing the position to 281,297 shares worth $35.5M. The position accounts for 0.16% of the portfolio, ranked #129.

Commerce Bank first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Commerce Bank held 281,297 shares of Gilead Sciences worth $35.5M as of Q2 2026.
  • Commerce Bank bought 201,812 Gilead Sciences shares in Q2 2026, an estimated $26.6M.
  • Gilead Sciences made up 0.16% of Commerce Bank's portfolio in Q2 2026, its #129 holding.
  • Commerce Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.